Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 10/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | TTR | P02766 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.50 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1479104 | 1.00 | GPR35 (0.59) | GPR35ALDH1A1KDM4EMEN1TTR | |
| SCHEMBL9724485 | 0.98 | GPR35 (0.57) | GPR35ALDH1A1KDM4EMEN1TTR | |
| SCHEMBL29780335 | 0.98 | GPR35 (0.57) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Ammonia Solution, Strong SCHEMBL11020682 | 0.98 | GPR35 (0.57) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Potassium Ion SCHEMBL1477825 | 0.95 | GPR35 (0.55) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Methyl Alcohol SCHEMBL29086960 | 0.95 | GPR35 (0.59) | GPR35ALDH1A1KDM4EMEN1TTR | |
| SCHEMBL4973651 | 0.91 | GPR35 (0.55) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Guanidine SCHEMBL4221122 | 0.89 | GPR35 (0.50) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Peroxynitrite SCHEMBL28967147 | 0.86 | GPR35 (0.47) | GPR35ALDH1A1KDM4EMEN1TTR | |
| Potassium Ion SCHEMBL6377633 | 0.85 | GPR35 (0.50) | GPR35ALDH1A1KDM4EMEN1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | claimed |
| EP-4658168-A2 | METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM | Biolinq, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | claimed |
| US-20250237601-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES | ALTI LLC | 2025-07-24 | — | — | US | claimed |
| EP-4518653-A1 | ANTIMICROBIAL COMPOSITION | Kamer, Patrick (CH) | 2025-03-12 | — | — | EP | claimed |
| US-20240315614-A1 | METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM | BIOLINQ INCORPORATED | 2024-09-26 | — | — | US | claimed |
| WO-2024163950-A2 | METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM | BIOLINQ INCORPORATED (US) | 2024-08-08 | — | — | WO | claimed |
| CN-115784943-B | Method for improving preparation selectivity of 2-sulfo-4, 6-dinitroresorcinol | 中石化南京化工研究院有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-11814332-B2 | Bismuth-based energetic materials | SELLIER & BELLOT A.S. (CZ) | 2023-11-14 | — | — | US | claimed |
| EP-0233063-A1 | Process and kit for drug detection | EREZ FORENSIC TECHNOLOGY, LTD. (IL) | 1987-08-19 | — | — | EP | claimed |
| EP-0047406-B1 | A METHOD OF FORMING A LEAD STYPHNATE COMPOUND PLUS BARIUM NITRATE IN SITU, FOR USE IN A PRIMING MIX | OLIN CORPORATION (US) | 1985-08-14 | — | — | EP | claimed |
| EP-0070932-B1 | INITIATORY EXPLOSIVE FOR DETONATORS AND METHOD OF PREPARING THE SAME | IDL CHEMICALS LIMITED (IN) | 1985-03-27 | — | — | EP | claimed |
| US-4412492-A | Priming composition and techniques | IMI KYNOCH LIMITED (GB) | 1983-11-01 | — | — | US | claimed |
| US-4405392-A | IN SITU PRODUCTION OF AZIDES OR STYPHNATES | IMPERIAL METAL INDUSTRIES (KYNOCH) LIMITED (GB) | 1983-09-20 | — | — | US | claimed |
| US-4402268-A | Electric primer for caseless propellant charges | Usel, Hubert (AU) | 1983-09-06 | — | — | US | claimed |
| EP-0070932-A2 | Initiatory explosive for detonators and method of preparing the same | IDL CHEMICALS LIMITED (IN) | 1983-02-09 | — | — | EP | claimed |
| US-4029530-A | STYPHNIC ACID REACTED WITH LEAD OXIDE, CARBONATE, OR HYDROXIDE | REMINGTON ARMS COMPANY, INC. (US) | 1977-06-14 | — | — | US | claimed |
| US-3983149-A | LEAD STYPHNATE | REMINGTON ARMS COMPANY, INC. (US) | 1976-09-28 | — | — | US | claimed |
| US-3953577-A | Process for purifying gases containing HCN | OSAKA GAS COMPANY, LIMITED (JA) | 1976-04-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | TES, TNPO1, SLC2A1 | GPR35 1862/4885ALDH1A1 4406/4885KDM4E 2829/4885 |
| US-20250275536-A1 | Antimicrobial Composition | CUTA, POLR1C, PIK3C3 | GPR35 3394/4885ALDH1A1 424/4885KDM4E 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.